Short Communication Factors Influencing Time to CD4+ T Cell Counts >200 Cells/mm3 in HIV-Infected Individuals with CD4+ T Cell <50 Cells/mm3 at the Time of Starting Combination Antiretroviral Therapy

被引:0
|
作者
Ku, Nam Su
Song, Young Goo
Han, Sang Hoon
Kim, Sun Bean
Kim, Hye-won
Jeong, Su Jin
Kim, Chang Oh
Kim, June Myung
Choi, Jun Yong [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea
基金
新加坡国家研究基金会;
关键词
MEDICINE ASSOCIATION; DISEASES SOCIETY; VIRAL LOAD; VIRUS; DIAGNOSIS; AIDS; RECOMMENDATIONS; DETERMINANTS; TUBERCULOSIS; PROGRESSION;
D O I
10.1089/aid.2011.0282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) starting combination antiretroviral therapy (cART). We included a total of 29 patients on successful cART for more than 1 year. In a logistic regression model, higher pre-cART CD4(+) T cell counts were significantly associated with shorter time to CD4(+) T cell counts >200cells/mm(3) in HIV-infected individuals with baseline CD4(+) T cell <50 cells/mm(3). In survival analysis, patients having higher pre-cART CD4(+) T cell counts, especially 40-49 cells/mm(3), were at significantly higher risk of achieving CD4(+) T cell counts >200 cells/mm(3).
引用
收藏
页码:1594 / 1597
页数:4
相关论文
共 50 条
  • [31] Discordant response of CD4+ T cells to antiretroviral therapy in HIV-infected patients coinfected with hepatitis C virus is accompanied by increased liver damage
    Shmagel, N. G.
    Shmagel, K. V.
    Saidakova, E. V.
    Korolevskaya, L. B.
    Chereshnev, V. A.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2015, 465 (01) : 358 - 360
  • [32] Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4+ T cell recovery can harbor replication-competent HIV despite viral suppression
    Real, Fernando
    Capron, Claude
    Sennepin, Alexis
    Arrigucci, Riccardo
    Zhu, Aiwei
    Sannier, Geremy
    Zheng, Jonathan
    Xu, Lin
    Masse, Jean-Marc
    Greffe, Segolene
    Cazabat, Michelle
    Donoso, Maribel
    Delobel, Pierre
    Izopet, Jacques
    Eugenin, Eliseo
    Gennaro, Maria Laura
    Rouveix, Elisabeth
    Borde, Elisabeth Cramer
    Bomsel, Morgane
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (535)
  • [33] Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl
    Kong, Chung Yin
    Sigel, Keith
    Criss, Steven D.
    Sheehan, Deirdre F.
    Triplette, Matthew
    Silverberg, Michael J.
    Henschke, Claudia I.
    Justice, Amy
    Braithwaite, R. Scott
    Wisnivesky, Juan
    Crothers, Kristina
    AIDS, 2018, 32 (10) : 1333 - 1342
  • [34] Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV plus Treatment-Naive Subjects With CD4+&lt;200 cell/mm3 in Mexico
    Sierra-Madero, Juan
    Villasis-Keever, Angelina
    Mendez, Patricia
    Luis Mosqueda-Gomez, Juan
    Torres-Escobar, Indiana
    Gutierrez-Escolano, Fernanda
    Juarez-Kasusky, Irene
    Magana-Aquino, Martin
    Ramos-Santos, Carmen
    Perez-Saleme, Leticia
    Rangel-Frausto, Sigfrido
    Antuna-Puente, Barbara
    Enrique Soto-Ramirez, Luis
    Lima, Vivian
    Belaunzaran-Zamudio, Franciso
    Crabtree-Ramirez, Brenda
    Montaner, Julio
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 (05) : 582 - 588
  • [35] CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy
    Resino, Salvador
    Seoane, Elena
    Gurbindo Gutierrez, Maria Dolores
    Antonio Leon, Juan
    Angeles Munoz-Fernandez, Maria
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (03) : 269 - 276
  • [36] Predictors of CD4+ T-Cell Counts of HIV Type 1-Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes
    Ledergerber, Bruno
    Costagliola, Dominique
    Lodwick, Rebecca
    Torti, Carlo
    van Sighem, Ard
    Podzamczer, Daniel
    Mocroft, Amanda
    Dorrucci, Maria
    Masquelier, Bernard
    Gunthard, Huldrych F.
    de Luca, Andrea
    Michalik, Claudia
    De Wit, Stephane
    Obel, Niels
    Fatkenheuer, Gerd
    Chrysos, George
    Mussini, Cristina
    Castagna, Antonella
    Stephan, Cristoph
    Garcia, Federico
    Zangerle, Robert
    Duval, Xavier
    Perez-Hoyes, Santiago
    Meyer, Laurence
    Ghosn, Jade
    Fabre-Colin, Celine
    Kjaer, Jesper
    Grarup, J.
    Chene, Genevieve
    Phillips, A.
    Dorrucci, M.
    Audelin, A.
    Cozzi-Lepri, Alessandro
    de Wolf, Frank
    Dorrucci, Maria
    Garcia, Federico
    Guenthard, Huldrych
    Jansen, Klaus
    Judd, Ali
    Lo Caputo, Sergio
    Meyer, Laurence
    Mussini, Cristina
    Noguera-Julian, Antoni
    Paraskevis, Dimitrios
    Paredes, Roger
    Perez-Hoyos, Santiago
    Pillay, Deenan
    Podzamczer, Daniel
    Ramos, Jose T.
    Tookey, Pat A.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (05) : 759 - 767
  • [37] Impact of HIV-1 Subtype on the Time to CD4+T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients
    Chow, Wei Zhen
    Lim, Sin How
    Ong, Lai Yee
    Yong, Yean Kong
    Takebe, Yutaka
    Kamarulzaman, Adeeba
    Tee, Kok Keng
    PLOS ONE, 2015, 10 (09):
  • [38] Evolution of CD4+ T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological Suppression
    Byakwaga, Helen
    Murray, John M.
    Petoumenos, Kathy
    Kelleher, Anthony D.
    Law, Matthew G.
    Boyd, Mark A.
    Emery, Sean
    Mallon, Patrick W.
    Cooper, David A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (06) : 569 - 576
  • [39] Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of ≥300/mm3:: CPCRA 059
    Abrams, DI
    Bebchuk, JD
    Denning, ET
    Davey, RT
    Fox, L
    Lane, HC
    Sampson, J
    Verheggen, R
    Zeh, D
    Markowitz, NP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (03) : 221 - 231
  • [40] Immunoregulatory T Cells May Be Involved in Preserving CD4 T Cell Counts in HIV-Infected Long-Term Nonprogressors and Controllers
    Gaardbo, Julie C.
    Ronit, Andreas
    Hartling, Hans J.
    Gjerdrum, Lise M. R.
    Springborg, Karoline
    Ralfkiaer, Elisabeth
    Thorsteinsson, Kristina
    Ullum, Henrik
    Andersen, Ase B.
    Nielsen, Susanne D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (01) : 10 - 18